A B S T R A C T The ability of the neutrophil myeloperoxidase-hydrogen peroxide-halide system to induce the release of human platelet constituents was examined. Both resulted in a small, although significant, release ofboth serotonin and adenine, suggesting some platelet lysis. Substantial release of these markers was observed only with increased H202 concentrations (>0.1 mM) or prolonged incubation (1-2 h).
INTRODUCTION
When the polymorphonuclear leukocyte (PMN)l is activated by phagocytosis, contact with nonphagocytosable immune reactant-coated surfaces, or exposure to certain soluble stimuli, it undergoes both metabolic activation and degranulation (1) (2) (3) . Although the primary role of these processes is considered to be the killing of ingested microorganisms within the phagocytic vacuole, leakage or secretion of toxic agents into the extracellular fluid can occur. Thus, the metabolic burst results in the formation of several reactive species of partially reduced oxygen, including superoxide anion, hydrogen peroxide (H202), and hydroxyl radical (2, 3) , and some of these agents have been detected in the extracellular fluid adjacent to the activated PMN (4) (5) (6) (7) (8) . Degranulation can result in the emptying of granule enzymes, such as acid hydrolases and myeloperoxidase, into the extracellular fluid (9) (10) (11) (12) (13) . The potential biological effects of these PMN secretory products have attracted considerable interest. Myeloperoxidase (MPO) plus H202 and a halide constitute a potent microbicidal system which is operative in the PMN (2, 3, 14) . This system is also toxic to several types of mammalian cells, including spermatozoa (15) , erythrocytes (16) , leukocytes (17) , and tumor cells (18) , raising the possibility that MPO and H202 released from activated PMN may affect nearby host cells. Phagocytosing PMN exert a cytotoxic effect on adjacent mammalian tumor cells which is mediated by the release of MPO and H202 (5) . Extracellular activity of MPO and H202 is further indicated by the fact that protein iodination by phagocytosing PMN, a phenomenon mediated by the MPO system, occurs in both extracellular and intracellular sites (19, 20) . Secreted H202 'Abbreviations used in this paper: DNP, dinitrophenol; DOG, 2-deoxy-D-glucose; MPO, myeloperoxidase; PBA, sodium phosphate buffer, 0.1 M, pH 6.5, with human albumin 1 mg/ml; PMN, polymorphonuclear leukocyte(s).
alone may exert nonenzymatic effects on certain types of mammalian cells (4, 8) .
Previous investigators have suggested the possibility of in situ interaction between PMN and platelets (8, (21) (22) (23) Other studies have reported effects of reagent H202 on various aspects of platelet physiology (24) (25) (26) (27) (28) . In this paper, we describe the initiation ofthe release reaction in human platelets by the MPO-H202-halide system.
METHODS
Platelet preparation. All processing was performed at room temperature with plastic tubes, syringes, and pipettes. Venous blood was drawn from normal adult volunteers, with potassium EDTA (K-EDTA) as the anticoagulant (10 ml of blood plus 0.2 ml of a 10% solution of K-EDTA). After centrifugation at 200 g for 10 min, the upper one-half of the platelet-rich plasma layer (-2 ml) was carefully aspirated without disturbing the lower erythrocyte layer. Ci/mmol, New England Nuclear) were used in similar concentrations. The platelet-rich plasma-serotonin-adenine mixture was incubated at room temperature for 40 min with occasional gentle mixing. It was then centrifuged at 500 g for 10 min and the platelet pellet was gently washed with 5 ml of 0.1 M sodium phosphate buffer, pH 6.5, containing human albumin (Sigma Chemical Co., St. Louis, Mo.), 1 mg/ml (PBA).
After centrifugation at 600 g for 10 min, the platelet pellet was again suspended in 5 ml ofPBA. An aliquot of0.01 ml was diluted in 0.99 ml of PBA, and the platelets in this suspension were counted in duplicate in a hemocytometer. The stock platelet suspension was then adjusted to contain 108 platelets/ ml of PBA.
Release assay. Radiolabeled platelets (0.05-ml sample of stock suspension containing 5 x 106 platelets) were incubated with the system components as detailed in the legends to the tables and figures. Incubations were performed in 12 x 75-mm polystyrene tubes with a total volume of 0.5 ml, in a 370C waterbath shaker oscillating 60 times/min. Immediately after incubation, the samples were centrifuged at 550 g for 10 min at 4°C. A portion of 0.2 ml of each sample supemate was placed in a liquid scintillation counter vial, 15 ml of Aquasol (New England Nuclear) was added, and counts of 3H and 14C determined in a Beckman LS-100 counter (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.). In each experiment, all samples were run in duplicate, and the values averaged. Standards included blank tubes (0.2 ml H20), platelet standards (0.05-ml platelets), and maximum release standards (0.05-ml platelets plus 0.45 ml 1% Triton X-100 [Sigma Chemical Co.] which was centrifuged as above and a 0.2-ml portion counted). The blank was subtracted from all samples and the release of each isotope was calculated as a percent of the maximum release standard. The release of both serotonin and adenine by Triton X-100 (maximum release standard) was essentially equal to the total contained in the platelet standard.
Special reagents. MPO was prepared from canine PMN by the method ofAgner (29) through the end of step 6. Peroxidase activity was determined by the o-dianisidine method (30); 1 U of activity is that causing the usage of 1 j,mol of substrate/min at 25°C (16) (Fig. 1) . MPG isolated from both dog and human PMN was effective.
The MPG system also induced the release of [14C]-adenine from labeled human platelets (Table I) (1 mM) 13.4±2.4 § (10) * Conditions were the same as described for the MPO-H202-chloride system in Table I except for the addition ofinhibitors as noted. Azide and cyanide were added as the sodium salts.
Canine MPO was used. (25, 26) . Ultrastructural studies indicated aggregation of platelets exposed to H202 in concentrations >1 mM (26) . H202 has not been reported to cause serotonin release from platelets (25) except in concentrations exceeding 1 mM (26). Holmsen and colleagues (27, 28) noted that incubation of platelets in H202 (.0.1 mM) resulted in decreases in platelet ATP, but the adenylate energy charge decreased only if ATP levels were more than two-thirds depleted. Under these conditions, H202 caused inhibition of shape change, primary aggregation, and secretion of constituents of dense granules and a-granules only if the decrease in adenylate energy charge exceeded 5%. Handin et al. (33) described the initiation of platelet aggregation and serotonin release by xanthine oxidase, a superoxidegenerating enzyme. Inhibition of these effects by superoxide dismutase, but not catalase or mannitol, suggested mediation by superoxide rather than H202 or hydroxyl radical. Longer incubation ofplatelets with xanthine oxidase caused release of radioactive sodium chromate, a cytoplasmic label, and this was blocked by catalase, but not superoxide dismutase. It was thus suggested that superoxide caused specific release of granule components, whereas H202 (formed by superoxide dismutation) caused lytic damage to the platelet. Our data document the release of platelet constituents by the MPO-H202-halide system. The release of serotonin, a dense-granule constituent, was employed as an indicator of the platelet release reaction, whereas the release of adenine was considered to be a lytic or cytotoxic event (34, 35) . If both serotonin and adenine are solubilized, but the former predominates, it may be inferred that both the release reaction and lysis are occurring.
Under our experimental conditions, brief exposure of platelets to H202 alone (20 ,uM) resulted in a small, although significant, release of adenine as well as serotonin, suggesting some platelet lysis. H202 alone initiated a large amount of release of these markers only at higher concentrations (>0.1 mM), or on prolonged exposure (1-2 h) to low concentrations. Serotonin release by H202 was markedly enhanced by the addition of MPO and a halide. The amount of adenine released by the MPO-H202-chloride system (-13%) was considerably less than the serotonin release (50%), which suggests that the peroxidase system triggers the nonlytic secretion of granule constituents independent of a lytic effect. Each component of the system (MPO, H202, halide) was required, and either chloride, bromide, iodide, or the pseudohalide, thiocyanate, could be employed. Chloride was effective in physiologic concentrations (0.1 M). Relatively low concentrations ofH202 (10 ,uM) could be employed, and serotonin release reached maximum levels in 2-5 min. Serotonin release by the MPO system was inhibited by the heme enzyme inhibitors, azide and cyanide, as well as by catalase. Although the inhibition by azide and cyanide appears to be a result ofan effect on the peroxidase, it should be noted that azide, but not cyanide, inhibits the platelet aggregation and release responses to collagen, ADP, and epinephrine by a direct effect on the platelet, the mechanism of which remains to be determined (27, 36) .
Chelation of Ca2+ by Mg-EGTA did not inhibit MPOinduced serotonin release, whereas chelation of both Ca2+ and Mg2+ by EDTA did, suggesting a requirement for Mg2+. DNP, an inhibitor of oxidative phosphorylation, partially blocked serotonin release, as did DOG, a glycolytic inhibitor, and maximal inhibition was achieved by a combination of DNP and DOG. Other aspects ofplatelet function are also maximally inhibited by simultaneously blocking oxidative and glycolytic pathways (37) (38) (39) (40) . This requirement for intact platelet metabolism to observe maximal release responses to the MPO system suggests an active process with respect to the platelets, as opposed to a passive lytic or cytotoxic process.
Thus, several lines of evidence indicate that the release of serotonin from platelets by the MPO system is primarily a nonlytic event analogous to the release reaction (34) . This hypothesis is supported by the rapidity of release, the marked predominance of serotonin release over adenine release, the divalent cation requirement, and the necessity for intact platelet metabolic activity. A lesser component of lytic release appears to be associated with a nonenzymatic effect of H202 alone.
In view of the ability of the MPO system to release platelet granule constituents and the known secretion of MPO and H202 by activated PMN (1, 2, (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) , it is reasonable to suggest an interaction between PMN and platelets mediated by this system. Levine et al. (8) have demonstrated that H202 formed by phagocytosing PMN can inhibit platelet aggregation responses to ADP. Their protocol, in which the PMN and platelets were separated by a dialysis membrane, might preclude the detection of an MPO-mediated effect as the large molecular weight of this enzyme (41, 42) would not allow passage through the membrane. It would be expected that an H202-mediated effect would be considerably enhanced by MPO in the presence of a suitable halide cofactor. Platelets contain H202-degrading enzyme systems (e.g., catalase and glutathione peroxidase [8, 27, 43] ) which may limit perturbation by low levels of H202. The protective effect of these enzymes might be overcome by increased H202 levels, by persisting low steady-state levels, or by successful competition for H202 by MPO.
Our studies, together with those of others (8, 22, 33) , suggest that activated PMN might influence platelets by several mechanisms, including superoxide anion, H202,or the MPO-H202-halide system. Further, the effect on platelets may be primary, i.e., initiation of release reactions, or secondary, i.e., impairment of the response to other stimuli. These observations may have important implications for hemostatic processes in vivo. The simultaneous presence of PMN and platelets in sites ofthrombus formation (44, 45) raises the distinct possibility that PMN products, such as MPO and H202, could promote the release of platelet constituents within the developing thrombus.
